A venture capital company with offices in the US is looking to make equity investments that can range from approx. $2-$15M depending on the opportunity. The firm is comfortable acting as both a lead or co-investor. The firm looks for companies primarily in the United States and will also consider companies from Europe and Canada.
The firm is primarily interested in sectors of therapeutics, life science tools, and digital health. In the Therapeutics space the firm is looking for both small molecule and biologics companies and is open to both platform and single asset companies. The firm is generally open to all indications but has significant expertise in the CNS space. Due to the firms two funds they are able and interested in investing in companies with products across the development cycle from preclinical – Phase III.
The firm is comfortable working with incomplete management teams and has assisted in hiring executive for portfolio companies in the past. The firm almost always look to take a board seat following investment.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment